Cargando…

Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting

Treatment of metastatic non-small cell lung cancer (mNSCLC) has been modified due to the development of immunotherapy. We assessed survival outcomes (overall [OS] and progression-free [rwPFS] survivals, time-to-next-treatment [TNT]) in mNSCLC patients after first-line immunotherapy and chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belaroussi, Yaniss, Bouteiller, Fanny, Bellera, Carine, Pasquier, David, Perol, Maurice, Debieuvre, Didier, Filleron, Thomas, Girard, Nicolas, Schott, Roland, Mathoulin-Pélissier, Simone, Martin, Anne-Laure, Cousin, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264352/ https://www.ncbi.nlm.nih.gov/pubmed/37311845 http://dx.doi.org/10.1038/s41598-023-36623-1

Ejemplares similares

One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study
por: Richez, Brice, et al.
Publicado: (2023)

Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database
por: Courtinard, Coralie, et al.
Publicado: (2023)

Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?
por: Belaroussi, Yaniss, et al.
Publicado: (2020)

Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer
por: Bellera, Carine A, et al.
Publicado: (2010)

Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF)
por: Greillier, Laurent, et al.
Publicado: (2022)

Breast cancer care compared with clinical Guidelines: an observational study in France
por: Lebeau, Marie, et al.
Publicado: (2011)

Suivi de la réponse sérologique au virus SARS-CoV-2 chez des professionnels de santé d'un centre de lutte contre le cancer dans un contexte de pandémie de COVID19 (PRO-SERO-COV)
por: Cantarel, C., et al.
Publicado: (2022)

Role of geriatric intervention in the treatment of older patients with cancer: rationale and design of a phase III multicenter trial
por: Soubeyran, Pierre, et al.
Publicado: (2016)

Effet de la 1,3,7-Trimethylxanthine en cas de maladie COVID-19. Étude bicentrique comparative : réduction de la durée d’hospitalisation
por: Bleibtreu, A., et al.
Publicado: (2020)

Brief Report on Teleconsultation in Lung Cancer: Toward a Semiotic Paradigm Shift?
por: Thomas, Quentin Dominique, et al.
Publicado: (2022)

One-Year Mortality in Older Patients with Cancer: Development and External Validation of an MNA-Based Prognostic Score
por: Bourdel-Marchasson, Isabelle, et al.
Publicado: (2016)

Systemic chemotherapy plus cetuximab after complete surgery in the treatment of isolated colorectal peritoneal carcinoma: COCHISE phase II clinical trial
por: Evrard, Serge, et al.
Publicado: (2019)

Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison
por: Penel, Nicolas, et al.
Publicado: (2023)

Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades
por: Toulmonde, Maud, et al.
Publicado: (2023)

Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial
por: Ravaud, A, et al.
Publicado: (2003)

Surrogate endpoints in advanced sarcoma trials: a meta-analysis
por: Savina, Marion, et al.
Publicado: (2018)

Radiofrequency ablation of stage IA non–small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial
por: Palussière, J., et al.
Publicado: (2018)

Futile lobectomies following video-thoracoscopic exploration for indeterminate pulmonary nodules: a retrospective study
por: Drevet, Gabrielle, et al.
Publicado: (2022)

Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy
por: Dupuis, Frantz, et al.
Publicado: (2018)

Effect of acute aerobic exercise before immunotherapy and chemotherapy infusion in patients with metastatic non-small-cell lung cancer: protocol for the ERICA feasibility trial
por: Gouez, Manon, et al.
Publicado: (2022)

Renal involvement is frequent in adults with primary mitochondrial disorders: an observational study
por: Bakis, Hugo, et al.
Publicado: (2022)

Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic Review
por: Filleron, Thomas, et al.
Publicado: (2021)

PRognostic factor of Early Death In phase II Trials or the end of ‘sufficient life expectancy’ as an inclusion criterion? (PREDIT model)
por: Grellety, Thomas, et al.
Publicado: (2016)

Laparoscopic fundoplication for para-oesophageal hernia repair improves respiratory function in patients with dyspnoea: a prospective cohort study
por: Bouriez, Damien, et al.
Publicado: (2022)

Satisfaction with care among patients with non-metastatic breast cancer: development and first steps of validation of the REPERES-60 questionnaire
por: Defossez, Gautier, et al.
Publicado: (2007)

The Ross Operation in Young Patients: A 15-Year Experience Focused on Right Ventricle to Pulmonary Artery Conduit Outcomes
por: Dib, Nabil, et al.
Publicado: (2022)

Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancer
por: Cousin, Sophie, et al.
Publicado: (2022)

A microsimulation model to assess the economic impact of immunotherapy in non-small cell lung cancer
por: Legoupil, Clémence, et al.
Publicado: (2020)

The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)
por: Pérol, David, et al.
Publicado: (2019)

Chronic granulomatous reaction in patients receiving vaccine immunotherapy for metastatic melanoma
por: Aria, Alexander B., et al.
Publicado: (2017)

Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study
por: Dromer, Françoise, et al.
Publicado: (2007)

Role of RAPID score and surgery in the management of pleural infection: a single center retrospective study
por: Simon, Laura, et al.
Publicado: (2023)

Prognostic significance of immunohistochemically detected breast cancer node metastases in 218 patients
por: de Mascarel, I, et al.
Publicado: (2002)

Using surveillance data to understand cancer trends: an overview in Morocco
por: Obtel, M., et al.
Publicado: (2015)

Anti-TNF, a magic bullet in cancer immunotherapy?
por: Montfort, Anne, et al.
Publicado: (2019)

Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study
por: Soubeyran, Pierre, et al.
Publicado: (2014)

Development of a Prognostic AI-Monitor for Metastatic Urothelial Cancer Patients Receiving Immunotherapy
por: Trebeschi, Stefano, et al.
Publicado: (2021)

Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic Cancer
por: Hue, Jonathan J., et al.
Publicado: (2021)

Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy
por: Gou, Miaomiao, et al.
Publicado: (2022)

When to proceed to surgical rib fixation?—A single-institution clinical experience
por: Belaroussi, Yaniss, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6bd7fo80ks5kqrjnsjtl65su2n